The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...
A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
According to the arrest documents, two of the drugs found in the lollipops are the active ingredients of popular weight-loss ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Lilly offers a similar deal for Zepbound. As insurance coverage expands, Hims’ competitive edge is disappearing. Can Hims Survive Without GLP-1s? Outside of weight loss, Hims’ core business is ...